Report for: Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study)

Title	Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study)
Published in	Trials, January 2020
DOI	10.1186/s13063-019-3734-4
Pubmed ID	31907007
Authors	Silje W Syversen, Guro L Goll, Kristin K Jørgensen, Inge C Olsen, Øystein Sandanger, Johanna E Gehin, David J Warren, Joseph Sexton, Cato Mørk, Jørgen Jahnsen, Tore K Kvien, Nils Bolstad, Espen A Haavardsholm

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Norway	3	100%

Type	Count	As %
Members of the public	2	67%
Scientists	1	33%

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	104	100%

Readers by professional status	Count	As %
Researcher	11	11%
Student > Ph. D. Student	10	10%
Student > Bachelor	8	8%
Other	7	7%
Student > Doctoral Student	6	6%
Other	18	17%
Unknown	44	42%

Readers by discipline	Count	As %
Medicine and Dentistry	29	28%
Nursing and Health Professions	7	7%
Pharmacology, Toxicology and Pharmaceutical Science	6	6%
Agricultural and Biological Sciences	4	4%
Unspecified	3	3%
Other	10	10%
Unknown	45	43%

Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study…